Palantir stock dipped slightly, but it’s still up big this year—cue dramatic music. Despite recent political scrutiny, the ...

Lawmakers were active stock traders in the days following Trump’s Liberation Day tariff announcement. A study of trades shows ...

As for Palantir, nine Wall Street analysts have a neutral or negative rating on the stock, and only two -- Wedbush and Bank ...

Palantir's stretched valuation leaves no margin of safety for investors. Click here to find out why PLTR stock is a Sell.

Palantir shows strong growth, major deals, and high free cash flow, but lofty valuation limits upside despite momentum. Read ...

Despite all of the uncertainty surrounding the capital markets, some stocks continue to rack up gains in 2025. One of the ...

However, Palantir is also the most expensive stock in the S&P 500, as measured by price-to-sales ratio. In fact, it is one of ...

PLTR has continued its stock market ascent, driven by relentless investor enthusiasm for its AI-powered platforms serving ...

Palantir counts Citi itself among its clients. The bank’s wealth division inked a deal with the company in mid-April. In a ...

Palantir Technologies Inc. ($PLTR) has captured the attention of investors with its cutting-edge AI and data analytics ...

So while there is concern about its valuation, what can investors expect from Palantir over the next year? 24/7 Wall St. did some analysis, so let’s take a look at. Palantir’s government line ...

NHS England has awarded a new contract to US data analytics company Palantir to transition existing NHS projects into a new federated data platform (FDP), prompting pushback from organisations ...